IL17A and psoriasis: investigated the incidence of herpes zoster in patients with psoriasis in the MarketScan data and found that the combination of corticosteroids with other drugs (disease‐modifying antirheumatic drugs and TNF inhibitors) showed a higher incidence than apremilast alone or IL‐17/23 inhibitors alone.23